[Ophthalmological care of SARS-CoV-2 positive patients in intensive care units].

Abstract

Early ophthalmological care of patients in intensive care with SARS-CoV‑2 (Severe-Acute-Respiratory-Syndrom-Corona-Virus-2) infections is very time-consuming; however, this approach might prevent other ophthalmological diseases, such as lagophthalmos. There is no difference in ophthalmological treatment between SARS-CoV‑2 positive and other intensive care patients. Due to the small number of cases in our observational study, a specific ophthalmological clinical pattern related to SARS-CoV‑2 infections cannot currently be identified; however, the increased occurrence of subconjunctival hemorrhage in intensive care SARS-CoV‑2 patients is remarkable. It remains unclear how ocular symptoms in SARS-CoV‑2 infections are related or how they occur in different stages of the disease. Therefore, further studies are necessary for representative statements.

• Authors: Luisa Schwarz, Christoph Lwowski, Ingo Schmack, Michael Müller, Elisabeth Adam, Kai Zacharowski, Thomas Kohnen
• Journal: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (Ophthalmologe) Vol. 117 Issue 7 Pg. 602-608 (Jul 2020) ISSN: 1433-0423 [Electronic] Germany
• Vernacular Title: Ophthalmologische Betreuung von stationären, intensivpflichtigen SARS-CoV-2-positiven Patienten.
• PMID: 32617666 (Publication Type: Journal Article, Review)

Topics

• Betacoronavirus
• COVID-19
• Coronavirus Infections
• Eye Diseases
• Humans
• Intensive Care Units
• Pandemics
• Pneumonia, Viral
• SARS-CoV-2